The partnership says that it “encourages” the study of neural crest stem cells as potential transplantable tissue for the repair of injury such as that sustained during traumatic brain injury or stroke, and for the repair of pathological and neurodegenerative processes such as those seen in Parkinson’s or Alzheimer’s diseases.
Stem cell research is likely to increase the understanding of the nervous system and may allow the development of treatments for currently incurable brain diseases and spinal cord injuries.
“The agreement makes it possible for us to establish neural crest stem cells as a candidate for development in therapies and treatments,” stated director of research, Dr Cyndi Chen. “Collaborating with Anti-Cancer will present a very promising future for both sides and for the medical community.”